By Marina Vieva · Founder, Amivi Advisory · Founder, Nascence AI
I sit on both sides of this one: I advise healthcare companies on financial and operational strategy, and I am building a clinical intelligence platform myself. From that double vantage point, the same blind spot appears in almost every healthcare AI pitch, budget, and diligence process I see.
Three things are converging — clinical intelligence, compliance exposure, and financial strategy — and most companies are only budgeting for one of them.
Healthcare AI founders plan meticulously for the technology — data pipelines, model performance, clinical validation. What rarely appears in the model: the cost of trust. HIPAA-grade infrastructure, audit trails, BAA negotiations with every enterprise client, security reviews that add months to sales cycles. These are not line items you discover gracefully; they surface mid-contract, when an enterprise client's counsel sends the liability rider.
I have watched a healthcare technology founder discover HIPAA exposure they did not know they had — alongside liability clauses in three enterprise contracts that could have been catastrophic. The fix was straightforward once found. Finding it before it detonated was the entire value.
Investors evaluating healthcare AI routinely apply SaaS gross-margin expectations to businesses whose cost of revenue quietly includes compliance overhead, clinical oversight, and security infrastructure. The result: valuations built on margins the company can't actually run at, discovered in the worst possible place — diligence. Founders who present compliance-loaded unit economics honestly stand out, because sophisticated healthcare investors know the naive version is fiction.
The hardest question in healthcare AI finance is not "does the model work?" It is "who pays, under what code, and when?" A clinically excellent product with no reimbursement pathway is a research project with a burn rate. Revenue models built on value-based care arrangements, shared savings, or payer contracts have timelines and cash dynamics that look nothing like SaaS — and financial plans that ignore this die of runway surprise, not product failure.
Healthcare rewards the companies that treat finance, compliance, and clinical value as one system. It punishes the ones that treat them as departments.